Skip to main content

INSMED Inc

For the period ended Mar 31, 2025. Filed May 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

INSM$119.49+2.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Shareholders' Equity (unaudited) for the and

Consolidated Statements of Shareholders' Equity (Deficit) (unaudited)

(in thousands)

Common Stock · AdditionalPaid-inCapital · Accumulated Deficit · AccumulatedOtherComprehensiveIncome (Loss) · Total
SharesAmount
Balance at December 31, 2023147,978$1,480$3,113,487$(3,446,145)$(745)$(331,923)
Comprehensive loss:
Net loss(157,091)(157,091)
Other comprehensive loss(891)(891)
Exercise of stock options and ESPP share issuance21724,0504,052
Net proceeds from issuance of common stock(409)(409)
Issuance of common stock for vesting of RSUs36644
Stock-based compensation expense21,45021,450
Balance at March 31, 2024148,561$1,486$3,138,578$(3,603,236)$(1,636)$(464,808)
Balance at December 31, 2024179,383$1,794$4,645,791$(4,359,917)$(2,289)$285,379
Comprehensive loss:
Net loss(256,583)(256,583)
Other comprehensive income1,3871,387
Exercise of stock options and ESPP share issuance2,0632029,68429,704
Issuance of common stock for vesting of RSUs45455
Issuance of common stock upon conversion of convertible notes55
Stock-based compensation expense39,26239,262
Balance at March 31, 2025181,900$1,819$4,714,742$(4,616,500)$(902)$99,159
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.